The Saudi Arabia IVF market is projected to grow from $306.59 million in 2024 to $522.39 million by 2033, driven by a 6.10% ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

The Diffuse Large B-cell Lymphoma (DLBCL) market is witnessing significant growth, driven by advancements in targeted immunotherapies like CAR-T cell therapy and bispecific antibodies. These therapies ...

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data ...

Deep application provides foundation for commercial execution PLEASANTON, Calif., July 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known ...

Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ...

A video of a street dog blocking the path of a Lamborghini Huracan supercar on a Mumbai street has made its way to X ...

Merck & Co., Inc. (NYSE:MRK) is one of the largest pharmaceutical companies in the world. The firm has benefited from its KEYTRUDA cancer drug over the past couple of years. However, Merck & Co., Inc.

Mamdani campaign spokesman Andrew Epstein said Mamdani is a Mets fan but has nothing to do with knockoff caps or its sellers.

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma's new chronic ...

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory ...

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /CNW/ -- An estimated 20 million people are diagnosed annually with cancer, while cancer kills ...